These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15895902)

  • 1. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus.
    Lilleby V; Flatø B; Førre O
    Clin Exp Rheumatol; 2005; 23(2):261-9. PubMed ID: 15895902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.
    Mak A; Mok CC; Chu WP; To CH; Wong SN; Au TC
    Lupus; 2007; 16(1):28-34. PubMed ID: 17283582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.
    Ravelli A; Duarte-Salazar C; Buratti S; Reiff A; Bernstein B; Maldonado-Velazquez MR; Beristain-Manterola R; Maeno N; Takei S; Gerloni V; Spencer CH; Pratsidou-Gertsi P; Ruperto N; Pistorio A; Martini A
    Arthritis Rheum; 2003 Aug; 49(4):501-7. PubMed ID: 12910556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
    Tarr T; Papp G; Nagy N; Cserép E; Zeher M
    Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S; Ye Z; Li C; Li Z; Li X; Wu L; Liu S; Zuo X; Zhu P; Wang Z; Wang Y; Wang Z; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2019 Apr; 28(5):635-641. PubMed ID: 30939980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study.
    Sit JKK; Chan WKY
    Pediatr Rheumatol Online J; 2018 Sep; 16(1):56. PubMed ID: 30201026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm glucocorticoid therapy.
    Tang XL; Zhu TY; Hung VW; Qin L; Wong CK; Kun EW; Tam LS; Li EK
    J Rheumatol; 2012 Oct; 39(10):1955-63. PubMed ID: 22896029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slicc damage index score in systemic lupus erythematosus patients and its associated factors.
    Ghazali WSW; Daud SMM; Mohammad N; Wong KK
    Medicine (Baltimore); 2018 Oct; 97(42):e12787. PubMed ID: 30334968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A descriptive study of the factors associated with damage in Malaysian patients with lupus nephritis.
    Shaharir SS; Ghafor AH; Said MS; Kong NC
    Lupus; 2014 Apr; 23(4):436-42. PubMed ID: 24399814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus in Saudi children: long-term outcomes.
    Al-Mayouf SM
    Int J Rheum Dis; 2013 Feb; 16(1):56-60. PubMed ID: 23441773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study.
    Miettunen PM; Pistorio A; Palmisani E; Ravelli A; Silverman E; Oliveira S; Alessio M; Cuttica R; Mihaylova D; Espada G; Pasic S; Insalaco A; Ozen S; Porras O; Sztajnbok F; Lazarevic D; Martini A; Ruperto N;
    Ann Rheum Dis; 2013 Sep; 72(9):1503-9. PubMed ID: 23100607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.